Advertisement
Financing › Details
Imegen (ES)–SEVERAL: investment, 201703 acquisition €10m of majority share in Imegen by Q-Growth Fund + Biolty
Period | 2017-03-16 | |
Money taker | Instituto de Medicina Genómica S.L. (Imegen S.L.) | |
Money source | SEVERAL | |
Product | genomic services | |
Product 2 | clinical genomic test (nucleic acid diagnostics) | |
Source | Bioval – Bioregion of Valencia (Valencia Square). (3/16/17). "News: Funds Q-Growth and Biolty Buy the Valencian Biotechnology Imegen by 10 Millions". Valencia, CA. | |
Record changed: 2017-04-12 |
Advertisement
More documents for Instituto de Medicina Genómica S.L. (Imegen S.L.)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top